US Food and Drug Administration · company speakers →
Dr. Timmons from the US Food and Drug Administration will discuss the phase-based approach to the chemistry, manufacturing, and control (CMC) regulation of CAR T cell products. This presentation will outline the regulatory expectations for CAR T cell products at different stages of development, as well as highlight best practices for avoiding CMC issues throughout the product lifecycle.
Is this you? Claim this profile →
No public contact links on file.
Sourcing speakers for your event?
Browse the speaker directory →